Table 3.
Demographic characteristics, cardiovascular risk factors, and laboratory test values in intubated patients who did and did not experience cardiovascular events
| Variables | Adverse CVE (+) n=26 | Adverse CVE (-) n=34 | p |
|---|---|---|---|
| Age, years | 66.9±14.9 | 61.2±13.1 | 0.01 |
| Male, n (%) | 21(82) | 17 (50) | 0.04 |
| HT, n (%) | 16 (60) | 14 (42) | 0.08 |
| DM, n (%) | 9 (36.4) | 8 (23.1) | 0.394 |
| History of CAD, n (%) | 4 (15.4) | 5 (15.2) | 0.980 |
| Dyslipidemia, n (%) | 4 (15.4) | 7 (21) | 0.767 |
| Infection, n (%) | 12 (45.5) | 13 (34.5) | 0.608 |
| Acute anterior wall MI, n (%) | 15 (58) | 20 (58) | 1.000 |
| Serum lactate, mmol/L | 8.3±4.1 | 4.4±2.3 | <0.001 |
| Hgb, g/dL | 10.3±2.1 | 14.0±1.8 | 0.005 |
| WBC, ×109/L | 17.5±5.0 | 13.9±6.1 | 0.035 |
| Neutrophil, ×109/L | 75.9±16.7 | 65.5±14.3 | 0.007 |
| Lymphocyte, % | 25.1±15.8 | 20.4±16.4 | 0.08 |
| Platelet count, ×109/L | 270.5±93.1 | 236.4±58.0 | 0.092 |
| Creatinine, mg/dL | 1.2±0.6 | 1.0±0.31 | 0.093 |
| TSH, mU/L | 2.0±2.8 | 1.3±1.5 | 0.364 |
| Total cholesterol, mg/dL | 158.5±41.0 | 178.1±47.2 | 0.216 |
| LDL-C, mg/dL | 96.1±36.4 | 108.9±42.2 | 0.380 |
| HDL-C, mg/dL | 39.0±11.1 | 38.8±11.5 | 0.959 |
| Triglyceride, mg/dL | 99.2±38.7 | 159.2±104.5 | 0.062 |
| LVEF, % | 27.8±6.7 | 40.3±11.1 | <0.001 |
CAD: Coronary artery disease; CVE: Cardiovascular event; DM; Diabetes mellitus, HDL-C; High-density lipoprotein cholesterol; Hgb; Hemoglobin; HT: Hypertension; LDL-C: Low-density lipoprotein cholesterol; LVEF: Left ventricular ejection fraction; MI: Myocardial infarction; TSH; Thyroid-stimulating hormone; WBC; White blood cell.